{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:46:29Z","timestamp":1785415589716,"version":"3.56.0"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union NextGenerationEU","award":["BG-RRP-2.004-0004-C01"],"award-info":[{"award-number":["BG-RRP-2.004-0004-C01"]}]},{"award":["BG-RRP-2.004-0004-C01"],"award-info":[{"award-number":["BG-RRP-2.004-0004-C01"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Methylxanthines, such as caffeine, exhibit neuroprotective properties in neurodegenerative conditions, partly linked to modulation of monoamine oxidase B (MAO-B) and oxidative stress pathways. This work aimed to design, synthesize and functionally characterize new caffeine-8-methylthioglycolic acid derivatives as selective MAO-B inhibitors with neuroprotective potential. Methods: A QSAR model was built on 94 studies of xanthine derivatives to guide the design of ten new semi- and thiosemicarbazides (Jas1\u2013Jas10), followed by molecular docking to human MAO-B (PDB: 2V5Z) using Glide, GOLD and MM-GBSA binding free energy calculations. The target compounds were synthesized in relatively high yields, structurally confirmed by spectroscopic methods and tested in vitro for hMAO-A\/B inhibition, as well as for neurotoxicity and neuroprotection in isolated mouse brain synaptosomes, mitochondria and microsomes under 6-hydroxydopamine (6-OHDA), tert-butyl hydroperoxide (t-BuOOH) and Fe\/ascorbate (Fe2+\/AA)-induced oxidative stress. Results: Docking and MM-GBSA identified Jas6 and Jas7 as the most stable MAO-B binders, with binding free energies approaching those of safinamide. All derivatives inhibited hMAO-A and hMAO-B in the submicromolar range, with Jas2 and Jas6 showing the highest MAO-B selectivity indices. At 100 \u00b5M, the series produced mild but significant pro-oxidant and cytotoxic effects when applied alone, yet under oxidative stress all compounds, especially Jas2 and Jas6, markedly preserved synaptosomal and mitochondrial viability, maintained glutathione levels, and reduced malondialdehyde production. Conclusions: The caffeine-based semi- and thiosemicarbazides, particularly Jas2 and Jas6, emerge as promising selective MAO-B inhibitors with pronounced antioxidant and neuroprotective activity, supporting their further optimization as multitarget candidates for neurodegenerative disorders such as Parkinson\u2019s disease.<\/jats:p>","DOI":"10.3390\/ph19060892","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:24:33Z","timestamp":1780629873000},"page":"892","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of In Silico QSAR and Molecular Docking Studies to a Series of Xanthine-Based Analogues and Design, Synthesis and Pharmacological Evaluation of Identified New Potential Selective MAO-B Inhibitors"],"prefix":"10.3390","volume":"19","author":[{"given":"Yavor","family":"Mitkov","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University\u2013Sofia, 2 Dunav str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-7213","authenticated-orcid":false,"given":"Emilio","family":"Mateev","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University\u2013Sofia, 2 Dunav str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6221-5002","authenticated-orcid":false,"given":"Iva","family":"Valkova","sequence":"additional","affiliation":[{"name":"Department Chemistry, Faculty of Pharmacy, Medical University\u2013Sofia, 2 Dunav str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4272-3579","authenticated-orcid":false,"given":"Stefan","family":"Kostov","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University\u2013Sofia, 2 Dunav str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kondeva-Burdina","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University\u2013Sofia, 2 Dunav str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1695-8454","authenticated-orcid":false,"given":"Alexander","family":"Zlatkov","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University\u2013Sofia, 2 Dunav str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zhang, H., and Speakman, J.R. (2024). The complexity of coffee and its impact on metabolism. J. Endocrinol., 262.","DOI":"10.1530\/JOE-24-0075"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"26208","DOI":"10.1021\/acsomega.5c00134","article-title":"New Prospects in the Inhibition of Monoamine Oxidase-B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer\u2019s Disease: A Review","volume":"10","author":"Chatzipieris","year":"2025","journal-title":"ACS Omega"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chandran, N., Lee, J., Prabhakaran, P., Kumar, S., Sudevan, S.T., Parambi, D.G.T., Alsahli, T.G., Pant, M., Kim, H., and Mathew, B. (2023). New Class of Thio\/Semicarbazide-Based Benzyloxy Derivatives as Selective Class of Monoamine Oxidase-B Inhibitors. Sci. Rep., 16.","DOI":"10.1038\/s41598-024-82771-3"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Monteiro, J.P., Alves, M.G., Oliveira, P.F., and Silva, B.M. (2016). Structure\u2013Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks. Molecules, 21.","DOI":"10.3390\/molecules21080974"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Haj Ahmed, W., Peiro, C., Fontaine, J., Ryan, B.J., Kinsella, G.K., O\u2019Sullivan, J., Grolleau, J.-L., Henehan, G.T.M., and Carp\u00e9n\u00e9, C. (2020). Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue. Medicines, 7.","DOI":"10.3390\/medicines7040018"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Jia, W., Huang, Z., Zhou, L., Liou, Y.C., Di Virgilio, F., Ulrich, H., Illes, P., Zhang, W., Huang, C., and Tang, Y. (2023). Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resist. Updates, 70.","DOI":"10.1016\/j.drup.2023.100988"},{"key":"ref_7","first-page":"483","article-title":"The therapeutic potential of monoamine oxidase inhibitors in Parkinson\u2019s disease","volume":"58","author":"Youdim","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_8","first-page":"425","article-title":"Monoamine Oxidase B Inhibitors in Parkinson\u2019s Disease","volume":"16","author":"Vecsei","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2174\/1570159X20666220905102144","article-title":"Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson\u2019s Disease: Beyond the Primary Mechanism of Action","volume":"21","author":"Rinaldi","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.2174\/1389557522666220413103529","article-title":"Role of Caffeine in the Age-Related Neurodegenerative Diseases: A Review","volume":"22","author":"Pohanka","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1038\/sj.bjp.0706464","article-title":"Monoamine oxidase: Isoforms and inhibitors in Parkinson\u2019s disease and depressive illness","volume":"147","author":"Youdim","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jones, D.N., and Raghanti, M.A. (2021). The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders. J. Chem. Neuroanat., 114.","DOI":"10.1016\/j.jchemneu.2021.101957"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1016\/j.bmc.2011.10.036","article-title":"Thio- and aminocaffeine analogues as inhibitors of human monoamine oxidase","volume":"19","author":"Booysen","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1016\/j.bmc.2012.10.005","article-title":"Inhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues","volume":"20","author":"Mostert","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1016\/j.ejmech.2011.05.014","article-title":"8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase","volume":"46","author":"Strydom","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bmc.2009.12.064","article-title":"Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues","volume":"18","author":"Strydom","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1016\/j.bmc.2012.05.048","article-title":"Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives","volume":"20","author":"Okaecwe","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"ref_19","first-page":"1099","article-title":"Validation through re-docking, cross-docking and ligand enrichment in various well-resoluted MAO-B receptors","volume":"13","author":"Mateev","year":"2022","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1573406415666190531121927","article-title":"Design, synthesis and evaluation of 8-thiosubstituted 1,3,7-trimethylxanthine hydrazones with in-vitro neuroprotective and MAO-B inhibitory activities","volume":"16","author":"Mitkov","year":"2020","journal-title":"Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejmech.2013.12.028","article-title":"Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase\/monoamine oxidase inhibitors for the potential treatment of Alzheimer\u2019s disease","volume":"75","author":"Esteban","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kasabova-Angelova, A., Kondeva-Burdina, M., Mitkov, J., Georgieva, M., Tzankova, V., and Zlatkov, A. (2020). Neuroprotective and MAOB inhibitory effects of a series of caffeine-8-thioglycolic acid amides. Braz. J. Pharm. Sci., 56.","DOI":"10.1590\/s2175-97902019000318255"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/jm00081a001","article-title":"Adenosine receptors: Pharmacology, structure\u2013activity relationships, and therapeutic potential","volume":"35","author":"Jacobson","year":"1992","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1021\/jm0104318","article-title":"Structure\u2013activity relationships of 8-substituted xanthines as antagonists at human A2B adenosine receptors","volume":"45","author":"Kim","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_25","first-page":"153","article-title":"Quantitative structure\u2013activity relationship (QSAR) studies on xanthine derivatives and related heterocycles","volume":"74","author":"Naeff","year":"1991","journal-title":"Helv. Chim. Acta"},{"key":"ref_26","first-page":"1","article-title":"3D-QSAR and molecular docking studies on xanthine oxidase inhibitors","volume":"1033","author":"Thakur","year":"2013","journal-title":"J. Mol. Struct. THEOCHEM"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1021\/jm031127c","article-title":"QSAR analysis of substituted heterocycles targeting xanthine-related enzymes","volume":"47","author":"Prusis","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/07391102.2008.10507183","article-title":"Molecular dynamics, flexible docking, virtual screening, ADMET predictions, and molecular interaction field studies to design novel potential MAO-B inhibitors","volume":"25","author":"Braun","year":"2008","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/0975-1483.100027","article-title":"Molecular Docking and prediction of pharmacokinetic properties of dual mechanism drugs that block MAO-B and adenosine A(2A) receptors for the treatment of Parkinson\u2019s disease","volume":"4","author":"Azam","year":"2012","journal-title":"J. Young Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1021\/acs.jmedchem.7b00918","article-title":"Coumarin versus chromone monoamine oxidase B inhibitors: Quo Vadis?","volume":"60","author":"Fonseca","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1074\/jbc.M110920200","article-title":"Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling","volume":"277","author":"Geha","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nsb732","article-title":"Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders","volume":"9","author":"Binda","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bmc.2019.02.004","article-title":"Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies","volume":"27","author":"Schabikowski","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"ref_34","first-page":"221","article-title":"Caffeine as an antioxidant: Inhibition of lipid peroxidation induced by reactive oxygen species","volume":"56","author":"Devasagayam","year":"1996","journal-title":"Food Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1079\/BJN20051370","article-title":"Is coffee a functional food?","volume":"93","year":"2005","journal-title":"Br. J. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.taap.2007.02.015","article-title":"Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework","volume":"222","author":"Calabrese","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0301-0082(99)00060-X","article-title":"Metabolism and functions of glutathione in brain","volume":"62","author":"Dringen","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"ref_38","unstructured":"(2024). Schr\u00f6dinger Release 2024-1: Protein Preparation Wizard, Epik, Schr\u00f6dinger, LLC."},{"key":"ref_39","unstructured":"(2024). Schr\u00f6dinger Release 2024-1: LigPrep, Schr\u00f6dinger, LLC."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0006-8993(94)91695-0","article-title":"Subcellular Fractionation on Percoll Gradient of Mossy Fiber Synaptosomes: Evoked Release of Glutamate, GABA, Aspartate and Glutamate Decarboxylase Activity in Control and Degranulated Rat Hippocampus","volume":"644","author":"Taupin","year":"1994","journal-title":"Brain Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0161-813X(02)00093-1","article-title":"Induction of GADD45 and GADD153 in Neuroblastoma Cells by Dopamine-Induced Toxicity","volume":"23","author":"Stokes","year":"2002","journal-title":"NeuroToxicology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jnr.10193","article-title":"\u03b2-Amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine","volume":"68","author":"Ferrera","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0003-9861(71)90334-1","article-title":"Reaction of Protein Disulfide Groups with Ellman\u2019s Reagent: A Case Study of the Number of Sulfhydryl and Disulfide Groups in Aspergillus Oryzae \u03b1-Amylase, Papain, and Lysozyme","volume":"147","author":"Robyt","year":"1971","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/6\/892\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:36:36Z","timestamp":1780630596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/6\/892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ph19060892"],"URL":"https:\/\/doi.org\/10.3390\/ph19060892","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}